Gallbladder cancer can occur in patients who have gallbladder polyps, gallstones with chronic inflammation and types of inflammatory bowel disease, such as ulcerative colitis and Crohn’s disease.
Gallbladder cancer originates in the gallbladder and its related tissue. Gallbladder cancer is also called cholangiocarcinoma.
Why choose the Cancer Therapy & Research Center (CTRC) for gallbladder cancer?
We have developed a multidisciplinary team that specializes in liver cancer, gallbladder cancer and other biliary tract cancers.
Your team specializing in Gall Bladder Cancer will include:
- Gastrointestinal (GI) medical oncologists
- Hepatologists, a physician that specializes in liver disease
- Surgical oncologists
- Radiation oncologists
- Radiologists, who specialize in imaging and treatment techniques
- Transplant surgeons, who specialize in gallbladder and liver surgery
- Pathologists, who specialize in liver and gallbladder pathology
Clinical trials at the CTRC
The CTRC is a National Cancer Institute (NCI) designated cancer center. The CTRC’s multidisciplinary cancer care teams specialize in all phases of clinical trials and we can help you navigate the steps involved in participating in a clinical trial if this is a treatment option you and your care team decide to pursue.
Patients who have been recently diagnosed, as well as those patients who have had prior treatment, can participate in clinical trials.
Experimental treatments and first-in-human clinical trials are available under special programs for patients who qualify for such treatment options.
Make an appointment
To request an appointment with our team or to make a referral to one of our physicians, please call the CTRC main number: (210) 450-1000 or 800-340-2872 or email CTRCReferral@uthscsa.edu.